Trafermin is a recombinant human basicfibroblast growth factor(rhbFGF). Trafermin is a potentFGFRinhibitor. Trafermin improves degree of re-epithelialization. Trafermin can be used in research in skin healing^[1].

Trafermin (trafermin is applied by spray) promotes skin healing in with cutaneous ulcer model mice and wound healing rates are 47.40% at 7 days and 93.61% at 14 days. Trafermin increases the expression of TGF-β1 and α-SMA^[1].

131094-16-1

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.